In addition, the high expression level of ARHGAP11A was associated with better prognosis in gastric and blood cancer, while correlated with poor prognosis in lung, bladder, breast and soft tissue cancer. Here, ARHGAP11A is linked to hematopoietic and lymphoid system neoplasm.